There's no prescription drug you can take here that is actually tested by the FDA. They work with the manufacturers to ensure the testing is thorough and accurate, but the company's themselves fund and conduct the testing.
http://www.fda.gov/drugs/resourcesforyou/consumers/ucm143534...
"Q: Does FDA test drugs?
A: No. It is the responsibility of the company seeking approval to market a drug to conduct laboratory and animal tests on the safety and effectiveness of a proposed new drug and then to submit that information to FDA for review by CDER physicians, statisticians, chemists, pharmacologists, and other scientist."
http://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm...
There's just simply no opportunity to test out a drug in 100 different studies with 100 different groups of people and cherry pick the study you want to submit to the FDA. The process doesn't work like that.
The FDA is required to approve the study plan, the pharma (or really, the contract research organization (CRO) acting on its behalf) reports back to the FDA. The FDA decides based on the reported study result (reported to the FDA) whether the drug can be marketed and under what constraints.
Why should tax payer pick up the tab on a clinical trial like this? Over the life time of a modern drug, the clinical trials required can easily approach $1B.
One of the key things that tipped me off was that they compared "prescription strength" Ibuprofen to Celebrex once, then didn't mention it again. I get that it is like for like (prescription for prescription), but the vast majority of people taking Ibuprofen are not taking prescription strength dosages.
This should not be "news" it should be given to doctors to consider. We probably need a medical body to review these types of papers to determine whether they are actionable by medical professionals.
The point of the study is to compare long-term, daily use of NSAIDs. It isn't saying that you should take Celebrex for a headache (nor could you as it requires a prescription).
You shouldn't be so quick to dismiss a study that you think is "obviously a commercial" if you aren't familiar with the subject matter at hand.
I'm not saying this study is bad, but studies paid for by corporations for their own gains should be the last we see running through news headlines. But of course, that is partly the effect they'd want from them...
if you don't toe the line with the result of your study, that'll be the last one you do for the entire industry.